Naren Singh
About Naren Singh
Naren Singh serves as the Director of US Commercial Strategy and Operations at Kite Pharma, bringing extensive experience in healthcare and business management. His career includes roles at Novartis and Tenet Healthcare, alongside a strong educational background in nursing and business administration.
Current Role at Kite Pharma
Naren Singh currently serves as the Director of US Commercial Strategy and Operations at Kite Pharma. He has held this position since 2023. In this role, he is responsible for overseeing commercial strategies and operational initiatives within the United States, contributing to the company's focus on innovative cell and gene therapies.
Previous Experience in Healthcare and Pharmaceuticals
Prior to his role at Kite Pharma, Naren Singh accumulated extensive experience in the healthcare and pharmaceutical sectors. He worked at Max Healthcare as a Registered Nurse from 2004 to 2007, and later at Tenet Healthcare as a Nurse Manager and Registered Nurse from 2007 to 2013. His transition to the pharmaceutical industry began at Novartis, where he held various positions, including Manager of Operations and Finance, Associate Director of Market Access Operations, and Associate Director of Strategy & PMO for Cell & Gene Therapies.
Educational Background
Naren Singh has a solid educational foundation in healthcare and business. He earned an Associate's degree in Nursing Education from Rajiv Gandhi University of Health Sciences and Mother Teresa College of Nursing. He furthered his studies at the University of Florida, obtaining a Bachelor of Science in Business Administration with a focus on Finance. Singh also holds a Master of Business Administration (MBA) from The Wharton School, enhancing his expertise in business strategy and operations.
Career Progression at Novartis
During his tenure at Novartis, Naren Singh progressed through several key roles from 2015 to 2022. He initially served as Manager of Operations and Finance, followed by the position of Associate Director in Market Access Operations. He then advanced to Associate Director of Strategy & PMO for Cell & Gene Therapies, where he contributed to strategic planning and project management within the organization.